Application

15594162 · QUANTIFICATION OF NON-REDUCING END GLYCAN RESIDUAL COMPOUNDS FOR DETERMINING THE PRESENCE, IDENTITY, OR SEVERITY OF A DISEASE OR CONDITION

Filed 2017-05-12 · Granted · Patent 10260084 (2019-04-16) The official file ↗The patent and its PDF ↗ · Art unit 1655 · Examiner Ralph J Gitomer Easy · CPC C12Q 1/40 · BIOMARIN PHARMACEUTICAL INC. · Jones Day for BioMarin

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

9.1 mo

to disposition 23.1 mo

Statutes raised

112 DP

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.